320 related articles for article (PubMed ID: 15660022)
1. Inhibition of corneal angiogenesis by local application of vasostatin.
Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules.
Dueñas Z; Torner L; Corbacho AM; Ochoa A; Gutiérrez-Ospina G; López-Barrera F; Barrios FA; Berger P; Martínez de la Escalera G; Clapp C
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2498-505. PubMed ID: 10509642
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
Bian F; Zhang MC; Zhu Y
Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of corneal neovascularization by rapamycin.
Kwon YS; Kim JC
Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.
Wang Y; Yin H; Chen P; Xie L; Wang Y
Ophthalmic Res; 2011; 46(2):66-72. PubMed ID: 21242701
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis.
Kuo CN; Yang LC; Yang CT; Lai CH; Chen MF; Chen CY; Chen CH; Wu PC; Kou HK; Chen YJ; Hung CH; Tsai CB
Exp Eye Res; 2009 Nov; 89(5):678-85. PubMed ID: 19596319
[TBL] [Abstract][Full Text] [Related]
10. Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits.
Koh CH; Lee HS; Chung SK
Cornea; 2014 May; 33(5):527-32. PubMed ID: 24608256
[TBL] [Abstract][Full Text] [Related]
11. The effect of curcumin on corneal neovascularization in rabbit eyes.
Kim JS; Choi JS; Chung SK
Curr Eye Res; 2010 Apr; 35(4):274-80. PubMed ID: 20373893
[TBL] [Abstract][Full Text] [Related]
12. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
13. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.
Xiao F; Wei Y; Yang L; Zhao X; Tian L; Ding Z; Yuan S; Lou Y; Liu F; Wen Y; Li J; Deng H; Kang B; Mao Y; Lei S; He Q; Su J; Lu Y; Niu T; Hou J; Huang MJ
Gene Ther; 2002 Sep; 9(18):1207-13. PubMed ID: 12215887
[TBL] [Abstract][Full Text] [Related]
14. The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.
Benelli U; Bocci G; Danesi R; Lepri A; Bernardini N; Bianchi F; Lupetti M; Dolfi A; Campagni A; Agen C; Nardi M; Del Tacca M
Exp Eye Res; 1998 Aug; 67(2):133-42. PubMed ID: 9733580
[TBL] [Abstract][Full Text] [Related]
15. A model of angiogenesis in the mouse cornea.
Kenyon BM; Voest EE; Chen CC; Flynn E; Folkman J; D'Amato RJ
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1625-32. PubMed ID: 8675406
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human epidermal growth factor and corneal neovascularization.
Nezu E; Ohashi Y; Kinoshita S; Manabe R
Jpn J Ophthalmol; 1992; 36(4):401-6. PubMed ID: 1289616
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of chemical cautery-induced corneal neovascularization by topical pigment epithelium-derived factor eyedrops.
Jin J; Ma JX; Guan M; Yao K
Cornea; 2010 Sep; 29(9):1055-61. PubMed ID: 20539216
[TBL] [Abstract][Full Text] [Related]
18. Potential anti-angiogenic role of Slit2 in corneal neovascularization.
Han X; Zhang MC
Exp Eye Res; 2010 Jun; 90(6):742-9. PubMed ID: 20298689
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Pathologic Corneal Neovascularization by Topical Application of a Novel Peptide In Vivo.
Lu Y; Xu Y; Gu Q; Xu X
Cornea; 2015 Oct; 34(10):1295-302. PubMed ID: 26266428
[TBL] [Abstract][Full Text] [Related]
20. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.
Amano S; Rohan R; Kuroki M; Tolentino M; Adamis AP
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):18-22. PubMed ID: 9430540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
